Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Miriam Saiz-Rodríguez"'
Autor:
Xandra García-González, Alberto M Borobia, Antonio J Carcas, Miriam Estébanez, Montserrat Carmona, Irene García García, Francisco Abad-Santos, Luis A López-Fernández, Esther Cubo, Iñaki Imaz-Iglesia, Alicia Marín-Candón, Miriam Saiz-Rodríguez, Irene Taladriz-Sender, Pedro Arias, Rocío Rosas-Alonso, Enrique Seco-Meseguer, Stefan Stewart, Elena Diago-Sempere, María del Mar García Saiz, Emilio J Laserna-Mendieta, Ana M Peiró, Magí Farré, Consuelo Rodriguez-Jimenez, Judith Sanabria-Cabrera, Lucia Pedrosa, Ignacio Bernardino, Javier Guiijarro-Eguinoa, Arturo Gómez López De Las Huertas, Susana Martín-López, Olga Hladun Alvaro, Vicente Arrate, Ana Fries, Daniel Rodriguez Díaz, Fernando Marqués García, Núria Alonso Pedrol, Modesto M Maestre Muñiz, Leticia Rodríguez Alcolado, Carlos Ortiz-Bautista, Angela Remesal-Doblado, María Isabel Lucena, Zaida Salmón González, Inmaculada Coca-Prieto
Publikováno v:
BMJ Open, Vol 14, Iss 11 (2024)
Introduction Genetic variations impact drug response, driving the need for personalised medicine through pre-emptive pharmacogenetic testing. However, the adoption of pre-emptive pharmacogenetic testing for commonly prescribed drugs, such as statins,
Externí odkaz:
https://doaj.org/article/fe076daeb0314b49a20a7cab8a12d654
Autor:
Ana Casajús, Pablo Zubiaur, Enrique Alday, Paula Soria‐Chacartegui, Miriam Saiz‐Rodríguez, Lara Gutierrez, Catalina Aragonés, Diana Campodónico, Antía Gómez‐Fernández, Marcos Navares‐Gómez, Gonzalo Villapalos‐García, Gina Mejía‐Abril, Dolores Ochoa, Francisco Abad‐Santos
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 1, Pp n/a-n/a (2024)
Abstract Tramadol is an important minor opioid prescribed for pain management. In this study, we analyzed the well‐known impact of CYP2D6 genetic variation and 60 additional variants in eight candidate genes (i.e., ABCG2, SLCO1B1, CYP2D6, CYP2B6, C
Externí odkaz:
https://doaj.org/article/4726d4d4aebd482ea7adce76f4619f4a
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 157, Iss , Pp 114003- (2023)
Externí odkaz:
https://doaj.org/article/67bcfc3dff4b4a46aa8377bf065fa707
Autor:
Dolores Ochoa, Manuel Román, Teresa Cabaleiro, Miriam Saiz-Rodríguez, Gina Mejía, Francisco Abad-Santos
Publikováno v:
BMC Pharmacology and Toxicology, Vol 21, Iss 1, Pp 1-9 (2020)
Abstract Background The pharmacokinetics of proton pump inhibitors (PPIs) may be affected by food intake. We aimed to evaluate the effect of food on the pharmacokinetics of omeprazole, rabeprazole, and pantoprazole. Setting The study population compr
Externí odkaz:
https://doaj.org/article/17aaf43e88004d65b811908c7d677f67
Autor:
Gonzalo Villapalos-García, Pablo Zubiaur, Marcos Navares-Gómez, Miriam Saiz-Rodríguez, Gina Mejía-Abril, Samuel Martín-Vílchez, Manuel Román, Dolores Ochoa, Francisco Abad-Santos
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Dutasteride and tamsulosin are one of the first-line combination therapies for the management of benign prostatic hyperplasia (BPH). Despite being more effective than monotherapies, they produce frequent adverse drug reactions (ADRs). Institutions su
Externí odkaz:
https://doaj.org/article/9978aa299f6f457b93b76f3768b48561
Autor:
Miriam Saiz-Rodríguez, Teresa Peña, Lourdes Lázaro, Ángel González, Andrés Martínez, José A. Cordero, Juan T. Vicente, Fernando Richard, María Jesús Coma, Martín de Frutos, Jorge Labrador, Ana Pueyo
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-3 (2020)
Abstract Objectives The aim of this study is to explore the effectiveness and safety of oral corticosteroids (prednisone) in the treatment of early stage SARS-Cov-2 pneumonia in patients who do not yet meet hospital admission criteria. Trial design R
Externí odkaz:
https://doaj.org/article/fbfcfdbca560470ba4fdaff4bc7251bb
Autor:
Dolores Ochoa, Miriam Saiz-Rodríguez, Esperanza González-Rojano, Manuel Román, Sergio Sánchez-Rojas, Aneta Wojnicz, Ana Ruiz-Nuño, Alfredo García-Arieta, Francisco Abad-Santos
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Purpose: Albendazole is a benzimidazole carbamate drug with anthelmintic and antiprotozoal activity against intestinal and tissue parasites. It has been described that the administration with meals increases albendazole absorption. Our aim was to com
Externí odkaz:
https://doaj.org/article/b53b5f228a6c43a5b0fb6aaf539537ac
Autor:
Pablo Zubiaur, Paula Soria-Chacartegui, Dora Koller, Marcos Navares-Gómez, Dolores Ochoa, Susana Almenara, Miriam Saiz-Rodríguez, Gina Mejía-Abril, Gonzalo Villapalos-García, Manuel Román, Samuel Martín-Vílchez, Francisco Abad-Santos
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 133, Iss , Pp 111087- (2021)
Olanzapine is an atypical antipsychotic widely used for the treatment of schizophrenia, which often causes serious adverse drug reactions. Currently, there are no clinical guidelines implementing pharmacogenetic information on olanzapine. Moreover, t
Externí odkaz:
https://doaj.org/article/de0a772e14e64e7ca07810fe61c423f4
Autor:
Álvaro Pinto-Merino, Jorge Labrador, Pablo Zubiaur, Raquel Alcaraz, María José Herrero, Pau Montesinos, Francisco Abad-Santos, Miriam Saiz-Rodríguez
Publikováno v:
Pharmaceutics, Vol 14, Iss 3, p 559 (2022)
Acute myeloid leukemia (AML) is a heterogeneous disease characterized by remarkable toxicity and great variability in response to treatment. Plenteous pharmacogenetic studies have already been published for classical therapies, such as cytarabine or
Externí odkaz:
https://doaj.org/article/b9a8767c3d894a099f2a1b2d63d5c4c3
Autor:
Gina Mejía, Miriam Saiz-Rodríguez, Beatriz Gómez de Olea, Dolores Ochoa, Francisco Abad-Santos
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
BackgroundAdverse drug reactions (ADR) are a public health issue, due to their great impact on morbidity, mortality, and economic cost.ObjectiveWe aimed to study the percentage of patients admitted urgently as a result of an ADR, considered serious a
Externí odkaz:
https://doaj.org/article/52a2c27b07bb4ce192180a9189fb85d5